Eldon C. Mayer III - 26 Jan 2023 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
Ex VP & Chief Commerc. Officer
Signature
/s/ Eldon C. Mayer III
Issuer symbol
EIGR
Transactions as of
26 Jan 2023
Net transactions value
$0
Form type
4
Filing time
30 Jan 2023, 20:25:00 UTC
Previous filing
14 Mar 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EIGR Stock Option (Right to Buy) Award $0 +31,500 $0.000000 31,500 26 Jan 2023 Common Stock 31,500 $1.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 50% on the first anniversary of the January 26, 2023 grant date, and as to the remaining 50% on June 26, 2024, subject to the Reporting Person's continuous service as of each such date. The option vests in full upon a change in control of the Issuer.